002821 Stock Overview Asymchem Laboratories (Tianjin) Co., Ltd. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Asymchem Laboratories (Tianjin) Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Asymchem Laboratories (Tianjin) Historical stock prices Current Share Price CN¥75.28 52 Week High CN¥110.22 52 Week Low CN¥59.55 Beta 0.14 1 Month Change -3.49% 3 Month Change -3.55% 1 Year Change -22.93% 3 Year Change -69.80% 5 Year Change -30.67% Change since IPO 379.49%
Recent News & Updates See more updates
Now 20% undervalued after recent price drop Jan 08
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025 Dec 31
Non-Executive Director recently bought CN¥304k worth of stock Dec 21 Asymchem Creates an Artificial Intelligence Platform to Address Key Challenges in Protein Design Nov 07
Earnings Troubles May Signal Larger Issues for Asymchem Laboratories (Tianjin) (SZSE:002821) Shareholders Nov 05
Third quarter 2024 earnings released: EPS: CN¥0.61 (vs CN¥1.45 in 3Q 2023) Oct 30
Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Oct 15
Investor sentiment deteriorates as stock falls 19% Oct 15
Executive VP & Executive Director recently bought CN¥1.8m worth of stock Oct 15
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump Sep 28
Investor sentiment improves as stock rises 19% Sep 27
CFO, Senior VP & Executive Director recently bought CN¥4.3m worth of stock Sep 18
Price target decreased by 8.9% to CN¥87.14 Sep 06
Second quarter 2024 earnings released: EPS: CN¥0.64 (vs CN¥2.94 in 2Q 2023) Aug 29
Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation? Jul 16
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80 Jun 27
Dividend of CN¥1.80 announced Jun 27
Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price Jun 26
Asymchem Appoints Cheng Yi Chen as CTO of Small-Molecule Sector Jun 26
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024 Jun 25 Asymchem Laboratories (Tianjin) Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 Jun 08
Asymchem Appoints Franck Mevellec as Senior Director, Business Development May 30
Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet? May 22
Consensus EPS estimates fall by 17% May 02
Price target decreased by 10% to CN¥103 Apr 27
First quarter 2024 earnings released: EPS: CN¥0.76 (vs CN¥1.72 in 1Q 2023) Apr 26
Consensus revenue estimates fall by 21% Apr 08
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next Apr 03
Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term Apr 02
Price target decreased by 10% to CN¥137 Mar 31
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Mar 30 Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 06, 2024
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023 Mar 28
A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Mar 26 Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024. Mar 09
Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26% Mar 04
Price target decreased by 7.0% to CN¥153 Mar 02
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024 Feb 29
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees Feb 05
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024 Dec 29
Now 23% undervalued after recent price drop Dec 04
New minor risk - Share price stability Nov 09
Price target increased by 7.3% to CN¥170 Nov 02
Price target increased by 8.7% to CN¥169 Nov 01
Third quarter 2023 earnings released: EPS: CN¥1.45 (vs CN¥2.71 in 3Q 2022) Oct 31
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Sun Xuejiao as Independent Non-Executive Director Sep 14
New major risk - Revenue and earnings growth Sep 02
Second quarter 2023 earnings released: EPS: CN¥2.94 (vs CN¥3.39 in 2Q 2022) Aug 30
Asymchem Laboratories (Tianjin) Co., Ltd. Implements Final Cash Dividend (A shares) for 2022, Payable on 21 July 2023 Jun 21
Asymchem Laboratories (Tianjin) Co., Ltd. Declares Final Dividend for the Year Ended 31 December 2022. Payable on 21 July 2023 Jun 10
Consensus revenue estimates fall by 14% Apr 06
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Mar 31 Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2022 Results on Mar 31, 2023
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Zhang Kun as an Independent Non-Executive Director Jan 17
Price target decreased to CN¥192 Nov 16
Less than half of directors are independent Nov 16
Consensus forecasts updated Nov 03
Price target decreased to CN¥209 Nov 02
Third quarter 2022 earnings released: EPS: CN¥2.71 (vs CN¥0.79 in 3Q 2021) Oct 28
Price target decreased to CN¥228 Oct 21
Price target decreased to CN¥253 Oct 01
Investor sentiment deteriorated over the past week Sep 16
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 800 million worth of its shares, under the authorization approved on September 2, 2022. Sep 07
Price target decreased to CN¥264 Aug 27
Second quarter 2022 earnings released: EPS: CN¥3.38 (vs CN¥0.81 in 2Q 2021) Aug 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2022 Results on Aug 25, 2022 Aug 16 Asymchem Laboratories (Tianjin) Co., Ltd. Provides Earnings Guidance for the Period Ended June 30, 2022
Price target decreased to CN¥354 Jul 15
Now 22% undervalued after recent price drop Jul 11
Asymchem Laboratories (Tianjin) Co., Ltd. Approves Cash Dividend for the Year 2021 Jun 11
Now 21% undervalued after recent price drop May 25
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022 May 14
Less than half of directors are independent Apr 27
Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 09, 2022 Apr 21
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021 Apr 01
Consensus forecasts updated Apr 01
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Dividend for the Year Ended December 31, 2021 Mar 31
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) entered into an agreement to acquire remaining 81.82% stake in Snapdragon Chemistry, Inc. for $57.9 million. Feb 12
Investor sentiment deteriorated over the past week Feb 11
Asymchem Laboratories (Tianjin) Co., Ltd. Provides Group Earnings Guidance for the Year Ending December 31, 2021 Jan 26
Less than half of directors are independent Jan 20
Asymchem Laboratories (Tianjin) Co., Ltd. has filed an IPO in the amount of HKD 7.550314 billion. Dec 01
Price target increased to CN¥414 Aug 19
Price target increased to CN¥357 Jun 22
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Dividend for 2020 May 21
First quarter 2021 earnings released: EPS CN¥0.64 (vs CN¥0.47 in 1Q 2020) Apr 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2020 Results on Apr 16, 2021 Mar 09 Shareholder Returns 002821 CN Pharmaceuticals CN Market 7D 1.7% 3.5% 4.2% 1Y -22.9% 2.8% 16.1%
See full shareholder returns
Return vs Market: 002821 underperformed the CN Market which returned 16.1% over the past year.
Price Volatility Is 002821's price volatile compared to industry and market? 002821 volatility 002821 Average Weekly Movement 5.6% Pharmaceuticals Industry Average Movement 5.6% Market Average Movement 7.0% 10% most volatile stocks in CN Market 11.0% 10% least volatile stocks in CN Market 4.1%
Stable Share Price: 002821 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002821's weekly volatility (6%) has been stable over the past year.
About the Company Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions.
Show more Asymchem Laboratories (Tianjin) Co., Ltd. Fundamentals Summary How do Asymchem Laboratories (Tianjin)'s earnings and revenue compare to its market cap? 002821 fundamental statistics Market cap CN¥25.90b Earnings (TTM ) CN¥769.03m Revenue (TTM ) CN¥5.57b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 002821 income statement (TTM ) Revenue CN¥5.57b Cost of Revenue CN¥3.24b Gross Profit CN¥2.33b Other Expenses CN¥1.56b Earnings CN¥769.03m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 29, 2025
Earnings per share (EPS) 2.17 Gross Margin 41.86% Net Profit Margin 13.80% Debt/Equity Ratio 0%
How did 002821 perform over the long term?
See historical performance and comparison Dividends
2.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/21 18:18 End of Day Share Price 2025/01/21 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Asymchem Laboratories (Tianjin) Co., Ltd. is covered by 27 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Bo Li BofA Global Research Yue Gao Changjiang Securities Co. LTD. Hao Wu Chasing Securities
Show 24 more analysts 
